Recurrence after Treatment for Pulmonary Multidrug-Resistant Tuberculosis

被引:23
作者
Becerra, Mercedes C. [1 ,2 ]
Appleton, Sasha C. [1 ,2 ,3 ]
Franke, Molly F. [1 ,2 ]
Chalco, Katiuska [2 ]
Bayona, Jaime [1 ,2 ]
Murray, Megan B. [3 ,4 ]
Mitnick, Carole D. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Socios Salud Sucursal Peru Partners Hlth, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA
基金
比尔及梅琳达.盖茨基金会;
关键词
FOLLOW-UP;
D O I
10.1086/655892
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We estimated the proportion of recurrence within 2 years among adults cured by individualized multidrug-resistant tuberculosis regimens in Peru. Among 310 individuals with at least 24 months of follow-up, 16 experienced an episode of recurrent tuberculosis. If we assume the worst for treatment effectiveness-that all 16 episodes were caused by the original tuberculosis strain-then 5.2% (95% confidence interval, 3.0%-8.2%) experienced true relapse. This is an upper-bound estimate of relapse on which new regimens must improve.
引用
收藏
页码:709 / 711
页数:3
相关论文
共 14 条
[1]   Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study [J].
Chiang, C-Y. ;
Enarson, D. A. ;
Yu, M-C. ;
Bai, K-J. ;
Huang, R-M. ;
Hsu, C-J. ;
Suo, J. ;
Lin, T-P. .
EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (05) :980-985
[2]   The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis [J].
Diacon, Andreas H. ;
Pym, Alexander ;
Grobusch, Martin ;
Patientia, Ramonde ;
Rustomjee, Roxana ;
Page-Shipp, Liesl ;
Pistorius, Christoffel ;
Krause, Rene ;
Bogoshi, Mampedi ;
Churchyard, Gavin ;
Venter, Amour ;
Allen, Jenny ;
Palomino, Juan Carlos ;
De Marez, Tine ;
van Heeswijk, Rolf P. G. ;
Lounis, Nacer ;
Meyvisch, Paul ;
Verbeeck, Johan ;
Parys, Wim ;
de Beule, Karel ;
Andries, Koen ;
Mc Neeley, David F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (23) :2397-2405
[3]  
Escudero E, 2006, INT J TUBERC LUNG D, V10, P409
[4]  
Fox W, 1999, INT J TUBERC LUNG D, V3, pS231
[5]  
Fraser HSF, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P270
[6]   Treatment Outcomes and Long-term Survival in Patients with Extensively Drug-resistant Tuberculosis [J].
Kim, Doh Hyung ;
Kim, Hee Jin ;
Park, Seung-Kyu ;
Kong, Suck-Jun ;
Kim, Young Sam ;
Kim, Tae-Hyung ;
Kim, Eun Kyung ;
Lees, Ki Man ;
Lee, Sung Soon ;
Park, Jae Seuk ;
Koh, Won-Jung ;
Lee, Chang-Hoon ;
Kim, Ji Yeon ;
Shim, Tae Sun .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (10) :1075-1082
[7]  
Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640
[8]   Comprehensive treatment of extensively drug-resistant tuberculosis [J].
Mitnick, Carole D. ;
Shin, Sonya S. ;
Seung, Kwonjune J. ;
Rich, Michael L. ;
Atwood, Sidney S. ;
Furin, Jennifer J. ;
Fitzmaurice, Garrett M. ;
Alcantara Viru, Felix A. ;
Appleton, Sasha C. ;
Bayona, Jaime N. ;
Bonilla, Cesar A. ;
Chalco, Katiuska ;
Choi, Sharon ;
Franke, Molly F. ;
Fraser, Hamish S. F. ;
Guerra, Dalia ;
Hurtado, Rocio M. ;
Jazayeri, Darius ;
Joseph, Keith ;
Llaro, Karim ;
Mestanza, Lorena ;
Mukherjee, Joia S. ;
Munoz, Maribel ;
Palacios, Eda ;
Sanchez, Epifanio ;
Sloutsky, Alexander ;
Becerra, Mercedes C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (06) :563-574
[9]   Randomized trials to optimize treatment of multidrug-resistant tuberculosis [J].
Mitnick, Carole D. ;
Castro, Kenneth G. ;
Harrington, Mark ;
Sacks, Leonard V. ;
Burman, William .
PLOS MEDICINE, 2007, 4 (11) :1730-1734
[10]   Programmes and principles in treatment of multidrug-resistant tuberculosis [J].
Mukherjee, JS ;
Rich, ML ;
Socci, AR ;
Joseph, JK ;
Virú, FA ;
Shin, SS ;
Furin, JJ ;
Becerra, MC ;
Barry, DJ ;
Kim, JY ;
Bayona, J ;
Farmer, P ;
Fawzi, MCS ;
Seung, KJ .
LANCET, 2004, 363 (9407) :474-481